# FDA Inspection 808721 - South Texas Blood & Tissue Center - November 26, 2012

Source: https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/c0d4c885-23c3-4f78-9671-960e73db782c
Source feed: FDA_Inspections

> FDA Inspection 808721 for South Texas Blood & Tissue Center on November 26, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 808721
- Company Name: South Texas Blood & Tissue Center
- Inspection Date: 2012-11-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 716219 - 2011-03-25](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/d3d698ff-119e-4c42-af5d-53f54fc33b69)
- [FDA Inspection 555798 - 2009-01-09](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/5f68e55c-147b-4015-bfe6-1a447b46afaa)

Company: https://www.keypedia.com/companies/south-texas-blood-tissue-center/1b43984f-e48d-439c-8f81-30188e9738f5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d